Evidence map›Paper›PMID 22666464›Full record

ArticlePloS one2012

Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element.

Amy S Labar, Jennifer S Millman, Ellen Ruebush, Japheth A Opintan, Rima A Bishar, A Oladipo Aboderin, Mercy J Newman, Adebayo Lamikanra, Iruka N Okeke

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Whole genome sequencing analysis of non-O157 Shiga toxin-producingIranian journal of veterinary research · 2024
    Article
  4. Review
  5. Epidemiology of Plasmids inAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Whole genome sequencing reveals high clonal diversity ofAntimicrobial resistance and infection control · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Emergence of Plasmid-Borne dfrA14 Trimethoprim Resistance Gene in Shigella sonnei.Frontiers in cellular and infection microbiology · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Amy S LabarDepartment of Biology, Haverford College, Haverford, Pennsylvania, United States of America.
Jennifer S Millman
Ellen Ruebush
Japheth A Opintan
Rima A Bishar
A Oladipo Aboderin
Mercy J Newman
Adebayo Lamikanra
Iruka N Okeke
Haverford College · USObafemi Awolowo University · NGUniversity of Ghana · GH

Funding

Howard Hughes Medical InstituteWellcome Trust
6 · The paper itself

Abstract

backgroundAntimicrobial resistance is a growing international problem. We observed a 50% increase in the prevalence of trimethoprim resistance among fecal Escherichia coli from healthy Nigerian students between 1998 and 2005, a trend to increase that continued in 2009. METHODS AND

findingsA PCR-based screen revealed that 131 (43.1%) of isolates obtained in Nigeria in 2005 and 2009 carried integron-borne dfrA cassettes. In the case of 67 (51.1%) of these isolates, the cassette was a class 1-integron-borne dfrA7 gene, which has been reported at high prevalence from E. coli isolates from other parts of Africa. Complete sequencing of a 27 Kb dfrA7-bearing plasmid from one isolate located the dfrA7 gene within a Tn21-type transposon. The transposon also contained an IS26-derived bla/sul/str element, encoding resistance to β-lactams, sulphonamides and streptomycin, and mercury resistance genes. Although the plasmid backbone was only found in 12 (5.8%) of trimethoprim-resistant isolates, dfrA7 and other transposon-borne genes were detected in 14 (16.3%) and 32 (26.3%) of trimethoprim resistant isolates collected in Nigeria in 2005 and 2009, respectively. Additionally, 37 (19.3%) of trimethoprim-resistant E. coli isolates collected between 2006 and 2008 from Ghana were positive for the dfrA7 and a transposon marker, but only 4 (2.1%) harbored the plasmid backbone.

conclusionsOur data point to transposition as a principal mechanism for disseminating dfrA7 among E. coli from Nigeria and Ghana. On-going intensive use of the affordable broad-spectrum antibacterials is likely to promote selective success of a highly prevalent transposable element in West Africa.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, MultipleEscherichia coliGenes, BacterialGenetic VectorsHumansIntegronsNigeriaPlasmidsTrimethoprimAnti-Bacterial AgentsTrimethoprim

Identifiers

PMID22666464
PMCPMC3364232
OpenAlexW2040656721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.